-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.P1.124 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I

Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Huihui Fu*, Xiaomei Zhang*, Sanxiu He*, Jun Li* and Yao Liu, phd, md*

Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Daria Gaut, MD1, Caspian Oliai, MD, MS1, Jonathan Boiarsky, MD2*, Shiliang Zhang, MD2*, Tali Azenkot, MD3*, Vanessa E. Kennedy, MD4, Vishesh Khanna, MD5, Karla Olmedo Gutierrez, MD6*, Navika D. Shukla, MD7*, Benjamin Moskoff, PharmD8*, Anand Ashwin Patel, MD9, Deepa Jeyakumar, MD6, Gabriel N. Mannis, MD10, Aaron C. Logan, MD, PhD11, Brian A. Jonas, MD, PhD12 and Gary J. Schiller, MD1

1UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
2Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
3Department of Internal Medicine, University of California Davis School of Medicine, Sacramento
4University of California San Francisco, San Francisco, CA
5Division of Hematology and Blood and Marrow Transplantation, Stanford University Hospital, Menlo Park, CA
6Division of Hematology/Oncology, UC Irvine Medical Center, Orange, CA
7Department of Medicine, University of Chicago, Chicago, IL
8Pharmacy Department, University of California Davis School of Medicine, Sacramento, CA
9Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
10Division of Hematology, Department of Medicine, Stanford University Medical Center, Menlo Park, CA
11Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
12Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA

Luis A. Carvajal, PhD1*, Tressa Hood, MS1*, Yana Bevan2*, Richard Dillon, MA PhD MRCP FRCPath3, Nicola Potter, PhD4*, Ian Thomas5*, Sean Johnson5*, Jad Othman, MBBS4, Amanda Gilkes6*, Nigel H. Russell, MD7, Adam Sikorski8*, Pete Ellis8*, Giovanni Marsico8*, Greg Jones8*, Crystal MacKenzie1*, Zung To1*, Jorge DiMartino, MD1 and Pavan Kumar, PhD1*

1Kronos Bio, Inc., San Mateo, CA
2King’s College London, London, United Kingdom
3Department of Medical and Molecular Genetics, King's College London, London, ENG, United Kingdom
4Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
5Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
6Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom
7Guy's Hospital, London, United Kingdom
8Inivata Ltd., Babraham Research Park, Cambridge, United Kingdom

Alexander Fischer, MSc, BSc1*, Roger Mulet-Lazaro, MSc2*, Margit Nützel1*, Stanley van Herk, BSc2*, Hanna Stanewsky1*, Ute Ackermann1*, Edith Reuschel, MD3*, Nicholas Strieder, PhD4*, Inmaculada Hernandez-Lopez, PhD4*, Wolfgang Herr, MD5, Peter J.M. Valk, PhD2, Michael Rehli, PhD4,5*, Ruud Delwel, MD2 and Claudia Gebhard, PhD1,4*

1Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
2Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
3Clinic St. Hedwig Regensburg, Regensburg, Germany
4Leibniz Institute for Immunotherapy, Regensburg, Germany
5Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany

Joshua J. Lara, BS1, Alfonso E. Bencomo2, Mayra A. Gonzalez3*, Idaly M. Olivas, MS2*, Jose L. Lopez1*, James E. Young, MS4*, Vanessa V. Velazquez1*, Steven Glovier, MS4*, Andres J. Rubio1*, Sara K. Dang, MS1*, Jonathan Solecki, BS4*, Jesse Allen, BS1*, Desiree N. Tapia, BS1*, Boranai Tychhon, BS1*, Gonzalo E. Astudillo, BS1*, Darshan S. Chandrashekar, PhD5* and Anna M. Eiring2

1Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX
2Department of Molecular and Translational Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX
3Department of Molecular and Translational Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX
4Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center at El Paso, El Paso, TX
5Department of Pathology-Molecular & Cellular, University of Alabama at Birmingham, Birmingham, AL

Inga Hund, M.Sc.1*, Maria Hess, M.Sc.2,3*, Julia Stomper, MD1*, Gabriele Greve, PhD1*, Jan Mitschke, PhD1*, Christoph Niemöller1*, Tobias Ma1*, David Uhl, MD1*, Felicitas R. Thol, MD4, Michael Heuser, MD4, Gesine Bug, MD5*, Martina Crysandt, MD6*, Lutz Peter Mueller, MD7*, Andreas Neubauer, MD8, Justus Duyster1,9*, Hartmut Dohner, MD10, Melanie Boerries, MD PhD2,3,9*, Heiko Becker, MD1,9* and Michael Luebbert, MD1,9

1Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3Faculty of Biology, University of Freiburg, Freiburg, Germany
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Goethe University Frankfurt, University Hospital, Dept. of Medicine, Hematology and Oncology, Frankfurt, Germany
6Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
7Department of Internal Medicine IV - Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
8Hematology, Oncology, Immunology, Philipps University, Marburg, Germany
9German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg, Germany
10Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Alyssa Obermayer1*, Sijie Yao, PhD1*, Jenny L. Smith, MSc, MEd2*, Rhonda E. Ries, MA3*, Yi-Cheng Wang, MS4*, Jason E Farrar, MD5, Scott N Furlan, MD6*, Tim Triche7*, Xiaotu Ma, PhD8*, Benjamin J. Huang, MD9*, Xuefeng Wang, PhD10*, Soheil Meshinchi, M.D., Ph.D.3,4,11,12 and Timothy I. Shaw, PhD13*

1Moffitt Cancer Center, Tampa, FL
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Children's Oncology Group, Monrovia, CA
5University of Arkansas For Medical Sciences, Little Rock, AR
6Fred Hutchinson Cancer Center, Seattle, WA
7Van Andel Institute, Grand Rapids, MI
8St. Jude Children's Research Hospital, Memphis, TN
9Dept. of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA
10Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
11Fred Hutchinson Cancer Research Center, Seattle, WA
12Department of Pediatrics, University of Washington, Seattle, WA
13Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL

Michael J. Hochman, MD1, Alexander J. Ambinder, MD, MPH1, Lukasz P. Gondek, MD, PhD2 and Amy E. DeZern, MD1

1Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Dorian Forte1*, Rafael J. Argüello, PhD2*, Roberto Maria Pellegrino3*, Husam B.R. Alabed3*, Martina Barone, PhD1*, Samantha Bruno, PhD1*, Francesco Fabbri, PhD4*, Ivan Vannini, PhD4*, Gianluca Cristiano, MD1*, Sandra Buratta, PhD3*, Lorena Urbanelli, PhD3*, Carla Emiliani, PhD3,5*, Michele Cavo, MD1,6* and Antonio Curti, MD, PhD7

1Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "Seràgnoli", University of Bologna, Bologna, Italy
2Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France
3Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy
4Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
5Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Perugia, Italy
6IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy
7IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy

Niveditha Ravindra, MD1*, Laura W. Dillon, PhD1*, Gege Gui1*, Christopher S. Hourigan, MD PhD1 and Alexander J. Ambinder, MD, MPH2

1Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
2Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Adam J. Lamble, MD1, Rhonda E. Ries, MA2*, Todd A. Alonzo, PhD3,4*, Yi-Cheng Wang, MS3*, Jason E Farrar, MD5, Benjamin J. Huang, MD6*, Matthew A. Kutny, MD7, Jessica A. Pollard, MD8, Richard Aplenc, MD, PhD9, Alan S. Gamis, MD, MPH10, Edward A. Kolb, MD11, Todd M. Cooper, DO1 and Soheil Meshinchi, M.D., Ph.D.12

1Seattle Children's Hospital, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
3Children's Oncology Group, Monrovia, CA
4Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
5University of Arkansas For Medical Sciences, Little Rock, AR
6Dept. of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA
7Department of Pediatrics, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
8Dana Building 3136, Dana-Farber Cancer Institute, Boston, MA
9Children's Hospital of Philadelphia, Philadelphia, PA
10Children's Mercy Kansas City, Kansas City, MO
11Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE
12Fred Hutchinson Cancer Center, Seattle, WA

Danielle C. Kirkey, MD1,2,3, Xiaoying Wu, PhD4*, Rhonda E. Ries, MA1*, Tiffany A. Hylkema, BS1*, Yanling Liu, PhD5*, Pandurang Kolekar, Ph.D5*, Quang Tran, PhD5, Alan S. Gamis, MD, MPH6, Richard Aplenc, MD, PhD7, Anders E. Kolb, MD8, Todd A. Alonzo, PhD9,10*, Katherine Tarlock, MD1,2,3, Robert Eisenman, PhD4* and Soheil Meshinchi, M.D., Ph.D.1,2,3

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Department of Pediatrics, University of Washington, Seattle, WA
3Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA
4Basic Science Division, Fred Hutchinson Cancer Center, Seattle, WA
5Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
6Hematology/Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO
7Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA
8Division of Oncology, Nemours/Alfred I. duPont Hospital For Children, Wilmington, DE
9Children's Oncology Group, Monrovia, CA
10Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA

Kinjal Bhadresha, PhD1*, Sanam Rezaei Benam, MSc1*, Alexander R. Maldeney, BSc1*, H. Scott Boswell, MD1,2, Reuben Kapur, PhD2,3 and Reza Shahbazi, PhD1,2,4

1Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
2Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN
3Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
4Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, IN

Marie Lue Antony, PhD1,2*, Klara E Noble-Orcutt, BS, MS1,2*, Jeffrey Lee Jensen, MD, PhD3*, Fiona He, MD1,2 and Zohar Sachs, MD, PhD1,2

1Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota, MINNEAPOLIS, MN
2Masonic Cancer Center, University of Minnesota, Minneapolis, MN
3Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC

Upaasana Krishnan1*, Beena E Thomas, Ph.D2*, Swati S Bhasin, PhD2,3, Hope L Mumme, BSc2,4* and Manoj Bhasin, PhD3

1Georgia Institute of Technology, School of Biological Sciences, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
4Department of Biomedical Informatics, Emory University, Atlanta, GA

Catherine Mark, MD1*, Edward A. Kolb, MD2, Bianca F. Goemans, MD, PhD3, Soheil Meshinchi, M.D., Ph.D.4, Brenda Gibson5*, Anke K. Bergmann, MD6*, Christine J. Harrison, PhD, FRCPath7, Cornelis Jan Pronk, MD, PhD8,9*, Hélène Lapillonne, MD, PhD10*, Guy Leverger11*, Evangelia Antoniou, MD12, Andishe Attarbaschi13*, Michael Dworzak, MD, PhD14*, Jan Stary, MD15*, Daisuke Tomizawa, MD, PhD16, Monika Lejman17*, Kjeld Schmiegelow, MD, DMSc18, Henrik Hasle, MD, PhD19, Brooklyn Joyce20*, Markus Schneider, PhD21* and Oussama Abla, MD22

1Toronto Hospital for Sick Children, Toronto, ON, Canada
2Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE
3Prinses Maxima Centrum, Utrecht, Netherlands
4Fred Hutchinson Cancer Center, Seattle, WA
5The Royal Hospital for Children, Glasgow, United Kingdom
6Department of Human Genetics, Hannover Medical School (MHH), Hannover, Germany
7Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom
8Lund University, Lund, SWE
9Childhood Cancer Center, Skane University Hospital, Lund, Sweden
10Pediatric Hematology and Oncology Department, Hôpital Armand Trousseau, Paris, France
11APHP, Paris, France
12Department of Pediatrics III, University Hospital Essen, Essen, Germany
13Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria
14Department of Pediatrics, St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
15Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
16Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
17Children's University Hospital, Lublin, Poland
18The Institute of Clinical medicine, The Faculty of Medicine, University of Copenhagen, Hellerup, Denmark
19Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark
20Toronto Hospital for Sick Children, Toronto, Canada
21Department of Pediatrics III, University Children’s Hospital Essen, University Duisburg-Essen, Essen, Germany
22Hospital for Sick Children Division of Hematology, Toronto, ON, Canada

Anna Stengel, PhD, Manja Meggendorfer, PhD, Wencke Walter, PhD*, Constance Baer, PhD, Niroshan Nadarajah*, Stephan Hutter, PhD*, Wolfgang Kern, MD, Torsten Haferlach, MD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Ka-Won Kang, MD, PhD1*, Jeong-An Gim1*, Kunye Kwak1*, Sunghoi Hong, PhD2*, Hyun Koo Kim, MD, PhD1*, Yeonho Choi, PhD2*, Ji-ho Park, PhD3* and Yong Park, MD, PhD1

1Korea University College of Medicine, Seoul, Korea, Republic of (South)
2Korea University, Seoul, Korea, Republic of (South)
3Department of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Seoul, Korea, Republic of (South)

Christian Rausch1*, Maja Rothenberg-Thurley, PhD1*, Annika Maria Dufour, PhD1*, Stephanie Schneider, PhD1,2*, Hanna Gittinger, MD1*, Maria Cristina Sauerland, MSc3*, Dennis Görlich, PhD4*, Utz Krug, MD5, Wolfgang E. Berdel, MD6, Bernhard Josef Woermann7, Wolfgang Hiddemann, MD, PhD1,8,9, Jan Braess, MD10*, Karsten Spiekermann8,9,11, Tobias Herold, MD1,8,9 and Klaus H Metzeler, MD12

1Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2University Hospital, LMU Munich, Institute of Human Genetics, Munich, Germany
3Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany
4Institute of Biostatistics and Clinical Research, University of Muenster, Münster, Germany
5Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany
6Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany
7German Society of Hematology and Oncology, Berlin, Germany
8German Consortium for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany
9German Cancer Research Center (DKFZ), Heidelberg, Germany
10Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany
11Department of Medicine III, Laboratory for Leukemia Diagnostics (LfL), University Hospital, LMU Munich, Munich, Germany
12Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

Arjan A. Van de Loosdrecht, MD, PhD1, Jacqueline Cloos, Prof1*, Eva-Maria Wagner-Drouet, MD2*, Uwe Platzbecker, MD3, Tobias A. W. Holderried, MD4*, Catharina van Elssen, MD, PhD5*, Aristoteles Giagounidis, MD6, Marij J.P. Welters, PhD7*, Sjoerd H. van der Burg7*, Hester J.T. van Zeeburg, PhD8*, Jeroen Rovers, MD, PhD8* and Bjorn T. Gjertsen, MD, PhD9,10

1Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands
2Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
3Universitätsklinikum Leipzig, Leipzig, Germany
4Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany
5Maastricht University Medical Centre, Maastricht, NLD
6Marien Hospital, Düsseldorf, Germany
7Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands
8Mendus AB, Stockholm, Sweden
9Haukeland Universitetssykehus, Bergen, Norway
10Haukeland University Hospital, Bergen, Norway

Sebastian Schwind, MD1*, Lara Bischof2*, Marius Bill, MD, PhD2*, Juliane Grimm, MD2*, Jule Ussmann, MD2*, Elizabeth Gaston, MD2*, Donata Backhaus, MD2*, Dominic Brauer, MD2*, Marco Herling, MD2*, Maximilian Merz, MD2, Klaus H. Metzeler, MD2, Georg-Nikolaus Franke, MD2*, Vladan Vucinic, MD2*, Uwe Platzbecker, MD2* and Madlen Jentzsch, MD3*

1Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Saxonia, Germany
2Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
3Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Sachsen, Germany

Prodromos Chatzikyriakou, PhD1*, Douglas RA Silveira, MD1*, Maria del Pilar Casares Aláez1*, Batchimeg Usukhbayar, PhD2*, Marlen Metzner, MSc3*, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath4, Anita K. Gandhi, PhD5, Alberto Risueño, PhD6*, Maroof Hasan, MD5* and Lynn Quek, MBBCh, DPhil, MRCP (UK), FRCPath1*

1School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
2University of Oxford, Oxford, GBR
3MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
4MRC Molecular Haematology Unit and Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals, Oxford, United Kingdom
5Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ
6Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain

Soichiro Nakako, MD1*, Hiroshi Okamura, MD, PhD1*, Isao Yokota, PhD, MPH2*, Yukari Umemoto1*, Yosuke Makuuchi, MD, PhD1*, Masatomo Kuno, MD, PhD1*, Teruhito Takakuwa, MD, PhD1*, Mitsutaka Nishimoto, MD, PhD1*, Asao Hirose, MD, PhD1*, Mika Nakamae, MD, PhD1*, Yasuhiro Nakashima, PhD, MD1*, Hideo Koh, MD, PhD1*, Masayuki Hino, MD, PhD1 and Hirohisa Nakamae, MD, PhD1*

1Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
2Biostatistics, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan

Onyee Chan, MD1, Najla Al Ali, MD1*, Hammad Tashkandi, MBBS2, Austin Ellis, MD3*, Somedeb Ball, MD1, Justin Grenet, MD4, Caroline Hana, MBBCh5, Yehuda E. Deutsch, MD6, Ling Zhang, MD7*, Mohammad O Hussaini, MD8*, Jinming Song, MD, PhD9*, Seongseok Yun, MD, PhD1, Chetasi Talati, MD1*, Andrew Kuykendall, MD10, Eric Padron, MD11, Alison R. Walker, MD1, Gail J. Roboz, MD12, Pinkal Desai, MD, MPH12, David A. Sallman, MD11, Kendra Sweet, MD11, Rami S. Komrokji1 and Jeffrey E. Lancet, MD1

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Moffitt Cancer Center, Tampa, FL
3Department of Pathology, Moffitt Cancer Center, Tampa, FL
4New York Presbyterian/Weill-Cornell Medical Center, New York, NY
5University of Miami/JFK Palm Beach Regional Campus, Boynton Beach, FL
6Department of Malignant Hematology and Cellular Therapy at Memorial Health System, Moffitt Cancer Center, Pembroke Pines, FL
7Department of Hematopathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Hematopathology and Lab Medicine, Moffitt Cancer Center, Tampa, FL
9Department of Hematopathology, Moffitt Cancer Center, Tampa, FL
10Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
11Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
12Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY

Claudia Sargas1*, Rosa Ayala2*, Maria Jose Larrayoz3*, Carmen Chillon, PhD4*, Estrella Carrillo5*, Cristina Bilbao, PhD6*, Esther Prados de La Torre7*, David Martinez-Cuadron8,9*, Rebeca Rodríguez-Veiga10*, Cristina Gil11*, Teresa Bernal, MD, PhD12*, Juan Miguel Bergua Burgués13*, Lorenzo Algarra14*, Mar Tormo15, Pilar Martínez Sánchez, M.D.16*, Elena Soria17*, Josefina Serrano18*, Juan Manuel Alonso Dominguez, MD, PhD19*, Raimundo García-Boyero20*, Maria Luz Amigo, MD21*, Pilar Herrera22*, María J. Sayas23*, Esperanza Lavilla24*, Joaquín Martínez-López, MD, PhD16*, María José Calasanz, PhD25*, Ramon Garcia-Sanz26, Jose A. Perez-Simon, MD, PhD17, María Teresa Gómez-Casares, MD, PhD27*, Joaquín Sánchez-Garcia, MD28, Eva Barragán9,29* and Pau Montesinos, PhD, MD30*

1Molecular Biology Unit, Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
2Hematology and Hemotherapy Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, CIBERONC, Madrid, Spain
3CIMA LAB Diagnostics-Universidad de Navarra, Pamplona, Spain, Pamplona, Spain
4Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain, Salamanca, Spain
5Instituto de Biomedicina (IBIS / CSIC), Universidad de Sevilla, Hospital Universitario Virgen del Rocio, Sevilla, Spain
6Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
7IMIBIC, Hematology, Hospital Universitario Reina Sofía, UCO, Cordoba, Spain
8Hematology Department, Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
9CIBERONC Instituto de Salud Carlos III, Madrid, Spain
10Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
11Hospital General Universitario de Alicante, Alicante, Spain
12Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de investigación del Principado de Asturias (ISPA), Oviedo, Spain
13Hospital San Pedro de Alcántara, Cáceres, Spain
14Hospital Universitario General de Albacete, Albacete, Spain
15Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
16Hematology Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, Madrid, Spain
17Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBIS / CSIC), Universidad de Sevilla, Sevilla, Spain
18Hospital Universitario Reina Sofía, Córdoba, Spain
19Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
20Hospital General Universitario de Castellón, Castellón de la Plana, Spain
21Hospital Universitario Morales Messeguer, Murcia, Spain
22Hospital Universitario Ramón y Cajal, Madrid, Spain
23Hospital Universitari Dr. Peset, Valencia, Spain
24Hospital Universitario Lucus Augusti, Lugo, Spain
25Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain
26Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
27Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
28IMIBIC, Hematology, Hospital Universitario Reina Sofía, UCO, Córdoba, Spain
29Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
30Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Lusha Cao, PhD, MS1*, Yang Xu, BS2,3*, Tina Glisovic-Aplenc, PhD4, Kevin Nestler, BS4*, Saar Gill, MD, PhD5, Kathrin M. Bernt, MD4,6, Benjamin A Garcia, PhD7*, Hossein Fazelinia, PhD1,8*, Lingyu Guan, PhD2,9*, Yi Xing, PhD1,2,9* and Richard Aplenc, MD, PhD4,6

1Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA
2Center for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA
3Graduate Group in Genomics and Computational Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
4Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA
5Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
6Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
7Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis
8Proteomics Core Facility, The Children's Hospital of Philadelphia, Philadelphia, PA
9Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Gege Gui1*, Abigail Wong-Rolle2*, Laura W. Dillon, PhD1*, Meghali Goswami, PhD1, Eddie Martin3*, Prajan Divakar4*, Jason Reeves, PhD4*, Katherine R. Calvo, MD, PhD5, Kasper D. Hansen, PhD6*, Christopher S. Hourigan, MD PhD1 and Chen Zhao, MD2*

1Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
2Thoracic and GI Malignancies Branch, NCI, Bethesda, MD
3Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD
4Nanostring Technologies, Inc., Seattle, WA
5Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
6Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

Sergiu Pasca1*, Matthew Guo, BA2, Shiyu Wang3*, Kristin Stokvis, CNP4*, Audra Shedeck, CRNP5*, Aparna Pallavajjala6*, Lisa Haley, MS7*, Cynthia Shams2*, Roshni Pallavajjala2*, Christopher D. Gocke, MD8*, Amy E. DeZern, MD9, Ravi Varadhan, PhD10*, Richard J. Jones, MD5 and Lukasz P. Gondek, MD, PhD11

1Johns Hopkins University, BALTIMORE, MD
2Johns Hopkins, Baltimore
3Johns Hopkins, Baltimore, MD
4Johns Hopkins Hospital, Baltimore
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
6Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD
7Johns Hopkins University School of Medicine, Baltimore, MD
8Division of Molecular Pathology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
9Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
10Oncology Biostatistics and Bioinformatics, Johns Hopkins University, Baltimore, MD
11Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Mark Wunderlich, MS1*, Jason Clark, MS2*, Jing Chen, PhD3* and Lynn Lee, MD2

1Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Marcus Matthias Schittenhelm, PD MD1*, Mihada Bajrami Saipi, MD2*, Gunnar Blumenstock3*, Peter JM Valk, PhD4, Balazs Györffy5* and Kerstin Maria Kampa-Schittenhelm, PD MD1,2

1Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
2Department of Hematology, Oncology, Rheumatology and clinical Immunology, University Hospital Tübingen, Tübingen, Germany
3Institute of Clinical Epidemiology and Applied Biometry, Eberhard Karls University Tübingen, Germany, University of Tuebingen, Tuebingen, Germany
4Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
5Dept. of Bioinformatics, TTK Momentum Cancer Biomarker Research Group, Budapest, Semmelweis University, Budapest, Hungary

Onyee Chan, MD1, Najla Al Ali, MS1, Somedeb Ball, MD1, Justin Grenet, MD2, Caroline Hana, MBBCh3, Yehuda E. Deutsch, MD4, Hammad Tashkandi, MBBS5, Ling Zhang, MD6*, Mohammad O Hussaini, MD7*, Seongseok Yun, MD, PhD1, Andrew Kuykendall, MD8, Eric Padron, MD1, Gail J. Roboz, MD9, Pinkal Desai, MD, MPH9, Rami S. Komrokji, MD5, Kendra Sweet, MD1, Jeffrey E. Lancet, MD1 and David A. Sallman, MD1

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2New York Presbyterian/Weill-Cornell Medical Center, New York, NY
3University of Miami/JFK Palm Beach Regional Campus, Boynton Beach, FL
4Department of Malignant Hematology and Cellular Therapy at Memorial Health System, Moffitt Cancer Center, Pembroke Pines, FL
5Moffitt Cancer Center, Tampa, FL
6Department of Hematopathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7Department of Hematopathology and Lab Medicine, Moffitt Cancer Center, Tampa, FL
8Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
9Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY

Blanca Boluda1*, Claudia Sargas2*, Rosa Ayala3*, Maria Jose Larrayoz4*, María Carmen Chillón Santos, PhD5*, Estrella Carrillo-Cruz, MD6*, Cristina Bilbao, PhD7*, Esther Prados de La Torre8*, Irene Navarro-Vicente9*, David Martinez-Cuadron1,10*, Rebeca Rodríguez-Veiga11*, Cristina Gil12*, Teresa Bernal del Castillo, MD13*, Juan Miguel Bergua Burgués14*, Lorenzo Algarra15*, Mar Tormo16, Pilar Martinez Sanchez, MD17*, Elena Soria18*, Josefina Serrano8*, Juan Manuel Alonso Dominguez, MD, PhD19*, Raimundo García-Boyero, MD20*, Maria Luz Amigo, MD21*, Pilar Herrera22*, Maria Jose Sayas23*, Esperanza Lavilla24*, Joaquín Martínez-López, MD, PhD25*, María José Calasanz, PhD26*, Ramon Garcia-Sanz5, Jose A. Perez-Simon, MD, PhD18, María Teresa Gómez-Casares, MD, PhD7*, Joaquín Sánchez-Garcia, MD8, Eva Barragán1,10* and Pau Montesinos, MD, PhD1*

1Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
2Molecular Biology Unit, Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
3Spanish National Cancer Research Center (CNIO), Madrid, Spain
4CIMA LAB Diagnostics-Universidad de Navarra, Pamplona, Spain, Pamplona, Spain
5Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
6Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBIS / CSIC / CIBERONC), Universidad de Sevilla, Sevilla, Spain
7Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
8IMIBIC, Hematology, Hospital Universitario Reina Sofía, UCO, Cordoba, Spain
9Hematology Department, Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
10CIBERONC Instituto de Salud Carlos III, Madrid, Spain
11Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
12Servicio de Hematología Clínica, Hospital General de Alicante, Alicante, Spain
13Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de investigación del Principado de Asturias (ISPA),, Oviedo, ESP
14Hospital San Pedro de Alcántara, Cáceres, Spain
15Hospital Universitario General de Albacete, Albacete, Spain
16Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
17Hematology Department, Hospital Universitario 12 de Octubre, CNIO, Madrid, Spain
18Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBIS / CSIC), Universidad de Sevilla, Sevilla, Spain
19Hospital Universitario Fundacion Jimenez Diaz - IISFJD-UAM, Madrid, Madrid, Spain
20Hospital Universitario General de Castellón, Castellón de la Plana, Spain
21Hospital Universitario Morales Messeguer, Murcia, Spain
22Hospital Universitario Ramón y Cajal, Madrid, Spain
23Hospital Universitario Dr. Peset, Valencia, Spain
24Hospital Universitario Lucus Augusti, Lugo, Spain
25Hematology Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, Madrid, Spain
26CIMA LAB Diagnostics-Universidad de Navarra, IdiSNA: Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain

Francisco Marchi, BS1, Fernando Sckaff2*, Xueyuan Cao, PhD3,4*, Raul C. Ribeiro, MD3, Jeffrey E. Rubnitz, MD5,6, Stanley B. Pounds, PhD7* and Jatinder K. Lamba, PhD8

1Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
2University of Florida, Gainesville
3St. Jude Children's Research Hospital, Memphis, TN
4Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, Memphis, TN
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6St. Jude Children's Hospital, Memphis, TN
7Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
8UF Health Cancer Center, Gainesville, FL

Norman Salomao1*, Nabih Maslah, PharmD, PhD2*, Anouk Giulianelli3*, Louis Drevon, MD4*, Lorea Aguinaga5*, Xiaolian Gu6*, Bruno Cassinat, PharmD, PhD2, Stephane Giraudier, MD, PhD7*, Pierre Fenaux8 and Robin Fahraeus1*

1INSERM UMR1131 -Institut de Recherche Saint Louis (IRSL - Hôpital St Louis) - Université de Paris, Paris, France
2INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
3APHP, Paris, France
4ApHP, paris, France
5APHP, Paris, FRA
6Umea University, Umea, Sweden
7INSERM UMR 1131, Saint-Louis Research Institute, Paris, France
8Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Olga Pérez-López1,2*, Marta Reinoso Segura3*, Clara B. Calderon Garcia, PhD4*, Noelia González-Carrasco5*, María Solé6*, Eduardo Rodriguez Arboli, MD7*, Concepción Prats-Martín, MD8*, Jose González Campos9*, Jose A. Perez-Simon, MD, PhD10 and Teresa Caballero, PhD2,10,11*

1Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain
2Department of Hematology, Hospital Universitario Virgen del Rocio; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla,Spain, Sevilla, Spain
3Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, ESP
4Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío of Sevilla, Sevilla, Spain
5Department of Hematology, Hospital Universitario Virgen Macarena, Sevilla, Spain
6Hospital Juan R. Jiménez, Huelva, Spain
7Instituto de Biomedicina de Sevilla (IBiS), UCG-Hematología, Hospital Universitario Virgen del Rocío, SEVILLA, Spain
8UCG-Hematología, Hospital Universitario Virgen del Rocío, Seville, Spain
9UCG-Hematología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
10Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
11University of Seville, MADRID, Spain

Joshua Tatarian1*, Stephen Hyter, PhD2*, Andrew K. Godwin, PhD2*, Daniel Farrell, MD2*, Tara L. Lin, MD3 and Haitham Abdelhakim, MD3

1University of Kansas School of Medicine, Kansas City, KS
2Department of Pathology & Laboratory Medicine, University of Kansas Cancer Center, Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS

Martina Crysandt, MD1,2,3,4*, Pia Krüger, MD5*, Steffen Koschmieder6,7,8, Ingo Kurth, MD9*, Tim H. Brümmendorf, MD7,10, Florian Kraft11* and Edgar Jost1,12*

1Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen, Germany
2Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
3Department of Internal Medicine IV, University Hospital RWTH Aachen, Aachen, Germany
4Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany
5Institute for Human Genetics and Genomic Medicine,, University Hospital RWTH Aachen, Aachen, Germany
6Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital of Aachen, Aachen, Germany
7Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
8Department of Medicine (Hematology, Oncology, Hemostaseology, and SCT), RWTH Aachen University, Aachen, Germany
9Institute of Human Genetics, University Hospital, Technical University (RWTH) Aachen, Aachen, Germany
10Department of Hematology and Oncology, Center for Integrated Oncology (CIO), Uniklinik RWTH Aachen, Aachen, Germany
11Institute for Human Genetics and Genomic Medicine, University Hospital RWTH Aachen, Aachen, Germany
12Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany

Andrew J. Menssen, PhD1, Chad A. Hudson, MD, PhD1, Todd A. Alonzo, PhD2,3*, Robert B. Gerbing, MA2*, Laura Pardo1,4*, Fan-Chi Hsu, PhD1*, Loren L. Lott1*, Fangyan Dai1*, Keely Ghiradelli1*, Yi-Cheng Wang, MS2*, E. Anders Kolb, MD2,5, Todd M. Cooper, DO6, Jessica A. Pollard, MD7,8, Michael R. Loken, PhD1*, Richard Aplenc, MD, PhD9, Lisa Eidenschink Brodersen, PhD1 and Soheil Meshinchi, M.D., Ph.D.2,10

1Hematologics, Inc., Seattle, WA
2Children's Oncology Group, Monrovia, CA
3Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Nemours Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE
6Seattle Children’s Hospital, Cancer and Blood Disorders Center, Seattle, WA
7Dana Building 3136, Dana-Farber Cancer Institute, Boston, MA
8Harvard Medical School, Boston, MA
9Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA
10Fred Hutchinson Cancer Center, Seattle, WA

Leo Ruhnke1*, Julia Frimmel1*, Christoph Röllig2*, Brigitte Mohr1*, Heidi Altmann1*, David Poitz3*, Sven Zukunft1*, Katrin Schranz4,5*, Sebastian Vosberg6*, Karsten Spiekermann4, Michael von Bergwelt, Prof. Dr.7*, Edgar Jost8*, Sabine Dressler9*, Kerstin Schäfer-Eckart9*, Triantafyllos Chavakis3*, Daniela Aust10*, Korinna Jöhrens10*, Gustavo Baretton10*, Martin Bornhäuser, MD1*, Philipp A. Greif4,5, Friedrich Stölzel1*, Sylvia Herold10* and Lisa Wagenführ1*

1Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
2Department of Internal Medicine I, Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dres, Dresden, Germany
3Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Dresden, Dresden, Germany
4Department of Medicine III, University Hospital Grosshadern, Ludwig-Maximilians University, Munich, Germany
5German Cancer Consortium (DKTK) partner site Munich, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany
6Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria
7Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
8Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany
9Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany
10Institute of Pathology, University Hospital Dresden, Dresden, Germany

Sebastian Wolf1,2,3*, Ashok Kumar Jayavelu, PhD4,5*, Florian Buettner, PhD1,3*, Gabriela Alexe, PhD6,7*, Björn Häupl, PhD1,2,3*, Constanze Schneider, PhD2,6,7*, Anne C Wilke, MD1,2,3*, Alena Zindel1,2,3*, Dominique Jahn1,2,3*, Bianca Splettstoesser4*, Julius Christoph Enssle, MD1,2,3*, Anjali Cremer, MD1,2,3*, Christoph Röllig8*, Christian Thiede, MD9, Björn Steffen, MD1,2,3*, Martin Bornhäuser, MD9,10*, Henning Urlaub, PhD11*, Kimberly Stegmaier, MD6,7, Hubert Serve, MD1,2,3, Matthias Mann, PhD4* and Thomas Oellerich, MD1,2,3*

1German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Frankfurt, Germany
2Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany
3Frankfurt Cancer Institute (FCI), Frankfurt, Germany
4Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Munich, Germany
5Hopp Children’s Cancer Center, University Hospital Heidelberg, Heidelberg, Germany
6Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
7Broad Institute of MIT and Harvard, Cambridge, MA
8Department of Internal Medicine I, Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dres, Dresden, Germany
9Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
10National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany
11Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany

*signifies non-member of ASH